Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Yibing Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9723-0678; OpenAlex author ID A5001376866. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 4 papers · 2025: 4 papers · 2026: 2 papers

Papers 16

  1. Metabolic plasticity in the pancreatic cancer metastatic cascade. First author DOI 10.1016/j.bbcan.2026.189622↗
  2. MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming. Co-author DOI 10.1016/j.jconrel.2026.115223↗
  3. 3D pancreatic ductal adenocarcinoma desmoplastic model: Glycolysis facilitating stemness via ITGAV-PI3K-AKT-YAP1. Co-author DOI 10.1016/j.bioadv.2025.214215↗
  4. 3D printed GelMA/HAMA based mechanical microenvironment boosted PDAC chemoresistance via NRF2-repressed ferroptosis. Co-author DOI 10.1016/j.colsurfb.2025.114816↗
  5. 3D printing-biomimetic local stiff niche enhances glycolysis to boost PDAC cell stem-like phenotype via N6-methyladenosine-suppressed YAP1 mRNA decay. Co-author DOI 10.1016/j.mtbio.2025.102176↗
  6. Matrix stiffness boosts PDAC chemoresistance via SCD1-dependent lipid metabolic reprogramming. Last author DOI 10.1093/rb/rbaf056↗
  7. Corrigendum to "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging … Co-author DOI 10.1016/j.canlet.2023.216603↗
  8. Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like p… Co-author DOI 10.1016/j.ijbiomac.2024.131826↗
  9. Piezo1 Mediates Glycolysis-Boosted Pancreatic Ductal Adenocarcinoma Chemoresistance within a Biomimetic Three-Dimensional Matrix Stiffness. Last author DOI 10.1021/acsbiomaterials.4c01319↗
  10. Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. Co-author DOI 10.1186/s12885-024-12365-9↗
  11. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy. Co-author DOI 10.1021/acsbiomaterials.3c00487↗
  12. Matrix stiffness triggers chemoresistance through elevated autophagy in pancreatic ductal adenocarcinoma. Last author DOI 10.1039/d3bm00598d↗
  13. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and t… Co-author DOI 10.1016/j.canlet.2021.04.030↗
  14. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA -200a sponging. Co-author DOI 10.1111/jcmm.16425↗
  15. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. Co-author DOI 10.7150/jca.25006↗
  16. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a. Co-author DOI 10.1016/j.yexcr.2017.07.039↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuhua Lu · 11 shared papers, 2017–2026 · strength 2.52
  2. Biwen Zhu · 6 shared papers, 2024–2026 · strength 1.74
  3. Jiashuai Yan · 6 shared papers, 2023–2025 · strength 1.41
  4. Xiaoqi Guan · 5 shared papers, 2024–2025 · strength 1.24
  5. Xihao Yao · 6 shared papers, 2021–2024 · strength 1.07
  6. Di Wu · 5 shared papers, 2023–2025 · strength 1.00
  7. Xue Zhang · 4 shared papers, 2024–2025 · strength 0.97
  8. Xiaohong Li · 6 shared papers, 2017–2024 · strength 0.86
  9. Di Wu · 3 shared papers, 2025 · strength 0.80
  10. Tiancheng Gong · 3 shared papers, 2023–2024 · strength 0.56
  11. Haopeng Pan · 3 shared papers, 2023–2024 · strength 0.56
  12. Yingqing Mao · 3 shared papers, 2021–2024 · strength 0.54
  13. Qingsong Guo · 2 shared papers, 2024 · strength 0.43
  14. Jingjing Lu · 3 shared papers, 2017–2024 · strength 0.41
  15. Yan Xue · 1 shared paper, 2026 · strength 0.30
  16. Dongzhi Wang · 1 shared paper, 2026 · strength 0.30
  17. Xingyu Jiang · 1 shared paper, 2026 · strength 0.30
  18. Yuhua Lu · 1 shared paper, 2024 · strength 0.22
  19. Yao Wang · 1 shared paper, 2024 · strength 0.22
  20. Zhiwei Wang · 2 shared papers, 2017–2021 · strength 0.19
  21. Haiyan Miao · 1 shared paper, 2021 · strength 0.14
  22. Hongquan Qiu · 1 shared paper, 2021 · strength 0.14
  23. Lei Wang · 1 shared paper, 2018 · strength 0.08
  24. Mingyan Zhu · 1 shared paper, 2018 · strength 0.08
  25. Yicheng Xiong · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.